The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy
Open accessAbstract
Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer (CRC) patients. The role of the differentially expressed lncRNAs in 5-Fluorouracil chemoresistance has not fully explained. Here, we observed lncRNA H19 was associated with the 5-Fu resistance in CRC. Quantitative analysis indicated that H19 was significantly increased in recurrent CRC patient samples. Kaplan–Meier survival analysis indicated that high H19 expression in CRC tissues was significantly associated with poor recurrent free survival. Our functional studies demonstrated that H19 promoted colorectal cells 5-Fu resistance. Mechanistically, H19 triggered autophagy via SIRT1 to induce cancer chemoresistance. Furthermore, bioinformatics analysis showed that miR-194–5p could directly bind to H19, suggesting H19 might work as a ceRNA to sponge miR-194–5p, which was confirmed by Dual-luciferase reporter assay and Immunoprecipitation assay. Extensively, our study also showed that SIRT1 is the novel direct target of miR-194–5p in CRC cells. Taken together, our study suggests that H19 mediates 5-Fu resistance in CRC via SIRT1 mediated autophagy. Our finding provides a novel mechanistic role of H19 in CRC chemoresistance, suggesting that H19 may function as a marker for prediction of chemotherapeutic response to 5-Fu.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198
Self-citationPharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002020 · Cited by 588
Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
Lin, C., & Yang, L. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.008 · Cited by 488
Lu, Y., Zhao, X., Liu, Q., Li, C., Graves-Deal, R., Cao, Z., Singh, B., Franklin, J. L., Wang, J., Hu, H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4424 · Cited by 425
Self-citationStintzing, S., Modest, D. P., Rossius, L., Lerch, M. M., von Weikersthal, L. F., Decker, T., Kiani, A., Vehling-Kaiser, U., Al-Batran, S.-E., Heintges, T., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30269-8 · Cited by 420
Research works printed but not linked: 35
- Marquez-Jurado, S. et al. Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression. Nat. Commun. 9, 389 (2018). · DOI
- Longley, D. B., Allen, W. L. & Johnston, P. G. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim. Biophys. Acta 1766, 184–196 (2006).
- Zhang, J., Wang, P., Wan, L., Xu, S. & Pang, D. The emergence of noncoding RNAs as Heracles in autophagy. Autophagy 13, 1004–1024 (2017). · DOI
- Baek, S. H. & Kim, K. I. Epigenetic control of autophagy: Nuclear events gain more attention. Mol. Cell 65, 781–785 (2017). · DOI
- Morel, E. et al. Autophagy: A druggable process. Annu. Rev. Pharmacol. Toxicol. 57, 375–398 (2017). · DOI · Paper page
- Kopp, F. & Mendell, J. T. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 172, 393–407 (2018). · DOI · Paper page
- Han, D. et al. Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 361, 13–21 (2015). · DOI · Paper page
- Xiong, X. D. et al. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells. Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother. 26, 28–42 (2016). · DOI
- Zhang, C. L., Zhu, K. P. & Ma, X. L. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 396, 66–75 (2017). · DOI · Paper page
- Xiong, H. et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene 36, 3528–3540 (2017). · DOI · Paper page
- Qu, L. et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 29, 653–668 (2016). · DOI · Paper page
- Fanale, D., Castiglia, M., Bazan, V. & Russo, A. Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer. Adv. Exp. Med. Biol. 937, 207–228 (2016). · DOI
- Engemann, S. et al. Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. Hum. Mol. Genet. 9, 2691–2706 (2000). · DOI
- Luo, M. et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 333, 213–221 (2013). · DOI · Paper page
- Berteaux, N. et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem. 280, 29625–29636 (2005). · DOI · Paper page
- Liang, W. C. et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6, 22513–22525 (2015). · DOI · Paper page
- Ohtsuka, M. et al. H19 noncoding RNA, an independent prognostic factor, regulates essential Rb-E2F and CDK8-beta-catenin signaling in colorectal cancer. EBioMedicine 13, 113–124 (2016). · DOI
- Han, D. et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget 7, 22159–22173 (2016). · DOI · Paper page
- Li, J., Hou, N., Faried, A., Tsutsumi, S. & Kuwano, H. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur. J. Cancer 46, 1900–1909 (2010). · DOI · Paper page
- Ou, X., Lee, M. R., Huang, X., Messina-Graham, S. & Broxmeyer, H. E. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells (Dayt., Ohio) 32, 1183–1194 (2014). · DOI · Paper page
- Zhang, Y. et al. Resveratrol enhances autophagic flux and promotes Ox-LDL degradation in HUVECs via upregulation of SIRT1. Oxid. Med. Cell Longev. 2016, 7589813 (2016). · DOI
- Jandura, A. & Krause, H. M. The new RNA world: Growing evidence for long noncoding RNA functionality. Trends Genet. : TIG 33, 665–676 (2017). · DOI · Paper page
- Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucl. Acids Res. 42, D92–D97 (2014). · DOI · Paper page
- Vennin, C. et al. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications. Cancer Lett. 385, 198–206 (2017). · DOI
- Lin, J. et al. Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression. Oncogene 37, 2432–2443 (2018). · DOI
- Zhang, L. et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34, 577–586 (2013). · DOI · Paper page
- Wang, Q. et al. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget 8, 2558–2567 (2017). · DOI
- Jiang, P. et al. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco. Targets Ther. 9, 3501–3509 (2016).
- Kemp, M. G. Crosstalk between apoptosis and autophagy: Environmental genotoxins, infection, and innate immunity. J. Cell Death 9, 1179670716685085 (2017). · DOI
- Schiedel, M., Robaa, D., Rumpf, T., Sippl, W. & Jung, M. The current state of NAD(+) -dependent histone deacetylases (Sirtuins) as novel therapeutic targets. Med. Res. Rev. 38, 147–200 (2018). · DOI
- Oon, C. E., Strell, C., Yeong, K. Y., Ostman, A. & Prakash, J. SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo. Eur. J. Pharmacol. 757, 59–67 (2015). · DOI
- Sun, L. N. et al. SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p. Cancer Lett. 409, 104–115 (2017). · DOI
- Dell'Aversana, C. et al. miR-194-5p/BCLAF1 deregulation in AML tumorigenesis. Leukemia 31, 2315–2325 (2017). · DOI
- Miao, J. et al. miR-194 suppresses proliferation and migration and promotes apoptosis of osteosarcoma cells by targeting CDH2. Cell. Physiol. Biochem. : Int. J. Exp. Cell. Physiol., Biochem., Pharmacol. 45, 1966–1974 (2018). · doi:10.1159/000487973
- Hu, H. et al. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer. Biosci. Rep. 38, (2018). pii: BSR20171428 https://doi.org/10.1042/BSR20171428. · DOI
Cited by
Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225758 · Cited by 605
Wei, L., Wang, X., Lv, L., Liu, J., Xing, H., Song, Y., Xie, M., Lei, T., Zhang, N., & Yang, M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1086-z · Cited by 339
Self-citationH19 lncRNA: Roles in tumorigenesis
Ghafouri-Fard, S., Esmaeili, M., & Taheri, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109774 · Cited by 277
Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Shoorei, H., Fattahi, F., Javadinia, S. A., Basiri, A., & Taheri, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.658636 · Cited by 193
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
Metadata
- Authors
- Wang, M., Han, D., Yuan, Z., Hu, H., Zhao, Z., Yang, R., Jin, Y., Zou, C., Chen, Y., Wang, G., Gao, X., & Wang, X.
- Venue
- Cell Death & Disease
- Published
- 2018-11-19
- Volume
- 9
- Issue
- 12
- Pages
- 1149-1149
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2901854772
- Cited by
- 186
- References
- 7
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. https://app.cochat.ai/papers/10.1038/s41419-018-1187-4
- The paper
- Wang, M., Han, D., Yuan, Z., Hu, H., Zhao, Z., Yang, R., Jin, Y., Zou, C., Chen, Y., Wang, G., Gao, X., & Wang, X. (2018). Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell Death & Disease. https://doi.org/10.1038/s41419-018-1187-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.